Dew - I'd love to see your thoughts/possibilities regarding substitutible biogenerics now that Gottlieb is in charge. (if I had to pick one thing Gottlieb has emphasized overwhelmingly, it is the need to enable more generics ASAP. No contest.)
Other than just speeding things up, what else might he lean on? What interim measures might he take?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.